Ovarian Cancer News

September Is National Ovarian Cancer Awareness Month (08/28/2008)
As the month of September brings ovarian cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer information throughout the year.

Dietary Flavonoids Reduce Risk of Ovarian Cancer (08/26/2008)
High consumption of plant-based foods that contain flavonoids may reduce the risk of ovarian cancer by nearly half. These results were recently published in the International Journal of Cancer.

Blood Test and Symptoms Help Detect Ovarian Cancer (06/30/2008)
Symptoms associated with ovarian cancer combined with a blood test can help detect ovarian cancer in its earliest, most treatable stages. These results were recently published in the journal Cancer.

Updates in the Management of Gynecologic Cancers (05/27/2008)
A Report from the 39^th Annual Meeting of the Society of Gynecologic Oncologists

Results from ChemoFX® Associated with Survival in Ovarian Cancer Patients (05/27/2008)
Results provided by the laboratory test ChemoFX® may improve survival among patients with ovarian cancer. These findings were published in the Journal of Clinical Oncology and will be presented at the upcoming 2008 annual meeting of the American Society of Clinical Oncology.

More...

Screening/Prevention

September Is National Ovarian Cancer Awareness Month (08/28/2008)
As the month of September brings ovarian cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer information throughout the year.

Dietary Flavonoids Reduce Risk of Ovarian Cancer (08/26/2008)
High consumption of plant-based foods that contain flavonoids may reduce the risk of ovarian cancer by nearly half. These results were recently published in the International Journal of Cancer.

Blood Test and Symptoms Help Detect Ovarian Cancer (06/30/2008)
Symptoms associated with ovarian cancer combined with a blood test can help detect ovarian cancer in its earliest, most treatable stages. These results were recently published in the journal Cancer.

Women Share Breast and Ovarian Cancer Testing Results with Family Members (04/25/2008)
Women who undergo testing for genetic breast cancer are more likely to share the results with other female family members, including children and their siblings, if they are aware of their relative’s opinion of genetic testing. These findings were recently published in the Journal of Family Psychology.

Fluctuation in Weight May Influence Risk for Ovarian Cancer (04/11/2008)
A large study conducted in Austria reveals that large weight gains or losses may influence an individual’s risk for developing certain types of cancer, including ovarian cancer. Complete details of the study were published in the Annals of Oncology.

More...

Stage I

September Is National Ovarian Cancer Awareness Month (08/28/2008)
As the month of September brings ovarian cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer information throughout the year.

Updates in the Management of Gynecologic Cancers (05/27/2008)
A Report from the 39^th Annual Meeting of the Society of Gynecologic Oncologists

Ovarian Cancer National Alliance Announces Eleventh Annual Conference (04/09/2008)
This year the Ovarian Cancer National Alliance will hold their eleventh annual conference, titled “Creating Currents of Change,” on Tuesday, July 8 through Thursday, July 10 at the Omni Shoreham Hotel in Washington, D.C.

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (03/31/2008)
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in gynecological cancers difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.

Specialty Hospitals Associated with Improved Survival in Early Ovarian Cancer (03/18/2008)
Hospitals that specialize in care for ovarian cancer are associated with significantly improved survival for women with early ovarian cancer. These results were recently reported in the Journal of the National Cancer Institute.

More...

Stage II-IV

September Is National Ovarian Cancer Awareness Month (08/28/2008)
As the month of September brings ovarian cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer information throughout the year.

Updates in the Management of Gynecologic Cancers (05/27/2008)
A Report from the 39^th Annual Meeting of the Society of Gynecologic Oncologists

Results from ChemoFX® Associated with Survival in Ovarian Cancer Patients (05/27/2008)
Results provided by the laboratory test ChemoFX® may improve survival among patients with ovarian cancer. These findings were published in the Journal of Clinical Oncology and will be presented at the upcoming 2008 annual meeting of the American Society of Clinical Oncology.

Ovarian Cancer National Alliance Announces Eleventh Annual Conference (04/09/2008)
This year the Ovarian Cancer National Alliance will hold their eleventh annual conference, titled “Creating Currents of Change,” on Tuesday, July 8 through Thursday, July 10 at the Omni Shoreham Hotel in Washington, D.C.

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (03/31/2008)
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in gynecological cancers difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.

More...

Recurrent

September Is National Ovarian Cancer Awareness Month (08/28/2008)
As the month of September brings ovarian cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer information throughout the year.

Ovarian Cancer National Alliance Announces Eleventh Annual Conference (04/09/2008)
This year the Ovarian Cancer National Alliance will hold their eleventh annual conference, titled “Creating Currents of Change,” on Tuesday, July 8 through Thursday, July 10 at the Omni Shoreham Hotel in Washington, D.C.

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (03/17/2008)
The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day administration. These results were recently reported at the 2008 annual Society of Gynecologic Oncologists meeting.

Avastin® Effective for Recurrent Ovarian Cancer (11/19/2007)
According to an article recently published in the Journal of Clinical Oncology, the targeted agent Avastin® (bevacizumab) appears to be effective and well tolerated for the treatment of recurrent ovarian cancer.

Avastin® May Provide Benefit in Recurrent Ovarian Cancer (10/03/2007)
According to an article recently published in the International Journal of Gynecological Cancer, the targeted agent Avastin® (bevacizumab) plus chemotherapy may provide anticancer activity in patients with recurrent ovarian cancer.

More...